NASDAQ$BTTC

Black Titan Corp · Q4 2019 earnings

Q4 2019 earnings · Reported Mar 30, 2020 (6 years ago) · Investor relations

Mar 30Dec 31, 2019

Total Revenue

$1.22M

Previous: $1.24M-1.6%

EPS (adj)

-$48.00

Previous: -$372.00+87.1%

Capital Expenditures

$112K

Previous: $345K-67.5%

Free Cash Flow

-$3.78M

Previous: -$3.65M-3.3%

Net Income

-$3.94M

Previous: -$3.5M-12.5%

Operating Income

-$3.79M

Previous: -$3.27M-16.2%

Gross Profit

$667K

Previous: $240K+177.9%

Cash & Equivalents

$5.22M

Previous: $9.3M-43.8%

Total Assets

$9.52M

Previous: $14.1M-32.4%

Stock-Based Comp

-$42K

Previous: $335K-112.5%

Titan Pharmaceuticals · Revenue · Quarterly

$1.22M

Q4 2019-1.6%vs Q4 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation